Ge Zhang, PhD
About Ge Zhang, PhD
Ge Zhang, PhD, is a Senior Manager of Scientific Strategy and Innovation at Entrada Therapeutics in Boston, MA. With a strong background in life sciences and business consulting, he specializes in evaluating technologies and developing commercialization strategies.
Work at Entrada Therapeutics
Ge Zhang has been serving as the Senior Manager of Scientific Strategy and Innovation at Entrada Therapeutics since 2021. In this role, he evaluates business opportunities for early-stage life sciences technologies that originate from academic laboratories. His responsibilities include preparing assessment reports for internal meetings and drafting marketing materials aimed at potential licensees. He also conducts market research and assesses licensing partners and intellectual property landscapes to support strategic decision-making.
Education and Expertise
Ge Zhang earned his Doctor of Philosophy (PhD) in Chemistry from Harvard University, where he studied from 2012 to 2018. Prior to this, he completed his Bachelor of Science (B.S.) in Chemistry at the University of North Carolina at Chapel Hill from 2008 to 2012. His educational background provides a strong foundation in scientific research and innovation, which he applies in his current role in the life sciences sector.
Background
Before joining Entrada Therapeutics, Ge Zhang worked at the Boston Consulting Group (BCG) as a Consultant from 2019 to 2020 in Chicago, Illinois. He then transitioned to Axiom Healthcare Strategies, where he continued as a Consultant from 2020 to 2021 in Boston, Massachusetts. His experience in consulting has equipped him with skills in developing commercialization strategies for life sciences technologies.
Professional Experience
Ge Zhang began his career as a Research Assistant at the University of North Carolina at Chapel Hill from 2009 to 2012. In this position, he gained valuable experience in scientific research, which laid the groundwork for his later roles in consulting and strategic management within the life sciences industry. His diverse professional background contributes to his expertise in evaluating and commercializing scientific innovations.